Skip to main content

Axcella Health Inc.

AXLADelisted Feb 15, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001633070

Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Axcella Health Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of AXLA: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders35350
Shares24.0M24.1M+85.8K (+0.4%)
Value$71.6M$50.4M−$21.2M (−29.6%)

New holders (5)

Institutions that held Axcella Health Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to AXLA in Q4 2021
InstitutionSharesValue% of portfolio
Virtu Financial LLC22,455$47.0K0.00%
Pinnacle Private Wealth, LLC20,500$43.0K0.01%
Lindbrook Capital, LLC11,500$24.0K0.00%
Susquehanna International Group, LLP10,020$21.0K0.00%
Advisor Group Holdings, Inc.2,150$4.00K0.00%

Sold out (5)

Institutions that held Axcella Health Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of AXLA in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Ergoteles LLC46,457$138.0K
Marshall Wace, LLP40,017$119.0K
HRT Financial LP37,142$110.0K
Barclays PLC2,316$7.00K
Global Retirement Partners, LLC180$1.00K